The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases

被引：0
|
作者：
Celine Aerts
Eliana Barrenho
Marisa Miraldo
Elisa Sicuri
机构：
[1] Universitat de Barcelona,ISGlobal, Hospital Clínic
[2] Imperial College London,Business School
[3] Employment,Organisation of Economic Co
[4] Labour and Social Affairs Directorate,operation and Development
[5] Health Division,Health Economics Group, Department of Infectious Disease Epidemiology, School of Public Health
[6] Imperial College London,undefined
来源：
Pharmaceutical Medicine | 2022年 / 36卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：189 / 197
页数：8
相关论文
共 50 条
  • [1] The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases
    Aerts, Celine
    Barrenho, Eliana
    Miraldo, Marisa
    Sicuri, Elisa
    [J]. PHARMACEUTICAL MEDICINE, 2022, 36 (03) : 189 - 197
  • [2] Correction to: The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases
    Celine Aerts
    Eliana Barrenho
    Marisa Miraldo
    Elisa Sicuri
    [J]. Pharmaceutical Medicine, 2022, 36 : 405 - 405
  • [3] The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases (vol 36, pg 189, 2022)
    Aerts, Celine
    Barrenho, Eliana
    Miraldo, Marisa
    Sicuri, Elisa
    [J]. PHARMACEUTICAL MEDICINE, 2022, 36 (06) : 405 - 405
  • [4] Is the priority review voucher program stimulating new drug development for tropical diseases?
    Kerr, Kirk W.
    Henry, Thomas C.
    Miller, Kathleen L.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (08):
  • [5] Impact of Priority Review Voucher Eligibility on Research and Development of Medical Countermeasures
    Wang, Stephanie
    Hahn, Georg
    Kesselheim, Aaron S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024,
  • [6] Impact Of The Priority Review Voucher Program On Drug Development For Rare Pediatric Diseases
    Hwang, Thomas J.
    Bourgeois, Florence T.
    Franklin, Jessica M.
    Kesselheim, Aaron S.
    [J]. HEALTH AFFAIRS, 2019, 38 (02) : 313 - 319
  • [7] THE EFFECTIVENESS OF THE FDA PRIORITY REVIEW VOUCHER FOR NEGLECTED TROPICAL DISEASES AND RARE PEDIATRIC DISEASES
    Wang, A.
    Chowdhury, C.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A229 - A229
  • [8] Association of the Priority Review Voucher With Neglected Tropical Disease Drug and Vaccine Development
    Jain, Nina
    Hwang, Thomas
    Franklin, Jessica M.
    Kesselheim, Aaron S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (04): : 388 - 389
  • [9] The Impact of the US Priority Review Voucher on Private-Sector Investment in Global Health Research and Development
    Robertson, Andrew S.
    Stefanakis, Rianna
    Joseph, Don
    Moree, Melinda
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2012, 6 (08):
  • [10] The Tropical Disease Priority Review Voucher: A Game-Changer for Tropical Disease Products
    Berman, Jonathan
    Radhakrishna, Tanya
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 96 (01): : 11 - 13
12345